Allspring Global Investments
EOLS icon

Allspring Global Investments’s Evolus EOLS Stock Holding History

Allspring Global Investments’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,260
Closed -$64.1K – 1781
2025
Q4 		$64.1K Buy
+10,260
New +$69.5K ﹤0.01% 1627
2024
Q4 		– Sell
-101
Closed -$1.64K – 1970
2024
Q3 		$1.64K Sell
101
-2,853
-97% -$39.9K ﹤0.01% 2282
2024
Q2 		$32K Sell
2,954
-4,208
-59% -$51.8K ﹤0.01% 2026
2024
Q1 		$100K Sell
7,162
-571
-7% -$7.42K ﹤0.01% 1844
2023
Q4 		$81.4K Sell
7,733
-4,612
-37% -$41.2K ﹤0.01% 1827
2023
Q3 		$113K Buy
12,345
+1,484
+14% +$13.3K ﹤0.01% 1954
2023
Q2 		$79K Buy
10,861
+9,114
+522% +$78.6K ﹤0.01% 2144
2023
Q1 		$14.8K Sell
1,747
-811
-32% -$7.33K ﹤0.01% 2549
2022
Q4 		$19.2K Buy
2,558
+759
+42% +$5.88K ﹤0.01% 2596
2022
Q3 		$14K Sell
1,799
-1,663
-48% -$17.6K ﹤0.01% 2674
2022
Q2 		$40K Sell
3,462
-12,000
-78% -$142K ﹤0.01% 2312
2022
Q1 		$173K Buy
15,462
+1,671
+12% +$14.2K ﹤0.01% 2617
2021
Q4 		$89K Buy
+13,791
New +$94.6K ﹤0.01% 2784

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's EOLS Position: Q1 2026 in Review

Allspring Global Investments sold out of Evolus (EOLS) in Q1 2026, closing a stake of 10,260 shares — an estimated $64.1K sold.

Allspring Global Investments first reported a position in EOLS in Q4 2021 and held it in 13 quarters. The position peaked at $173K in Q1 2022. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Allspring Global Investments reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Allspring Global Investments sold 10,260 Evolus shares in Q1 2026, an estimated $64.1K.
  • Allspring Global Investments first reported a position in Evolus in Q4 2021 and held it in 13 quarters.
  • Allspring Global Investments's Evolus position peaked at $173K in Q1 2022.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.